Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral contraceptive pill for prevention of bacterial vaginosis recurrence
ACTRN12613001147774Phase 3Terminated
- Sponsor
- University of Melbourne
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ethinylestradiol + levonorgestrel in bacterial vaginosis (BV), sponsored by University of Melbourne. Started Jul 2014; status: terminated.
02
Drugs
ethinylestradiol + levonorgestrel
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on ACTRN12613001147774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613001147774.